Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth

Overview

Retrospective observational study to determine the efficacy of remifentanil during the delivery. Authors will search the data in period between 2010 and 2014 in cohort of 100 parturients and obtain data of analgesic efficacy (VAS score after remifentanil analgesia induction) and parturients satisfaction with the method.

Full Title of Study: “Efficacy and Satisfaction With Remifentanil Analgesia in Parturients During the Childbirth: Retrospective Observational Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: January 2015

Detailed Description

In retrospective observational study will authors search the documentation of parturients. The cohort size is estimated to 100 subjects, in period between 2010-2014. Excluded will be all patients who did not signed the informed consent for processing with their medical data.The main aim is to evaluate the efficacy of the remifentanil analgesia in parturients in the first phase of delivery. The analgesic efficacy will be evaluated by the change in VAS (visual analogue scale) score after induction of remifentanil analgesia Satisfaction will be evaluated by the questionary.

Interventions

  • Drug: remifentanil
    • Remifentanil analgesia during delivery

Arms, Groups and Cohorts

  • Parturients with remifentanil analgesia
    • Parturients after induction of remifentanyl analgesia during the delivery

Clinical Trial Outcome Measures

Primary Measures

  • Efficacy of remifentanyl analgesia during the delivery
    • Time Frame: VAS score before the induction of remifentanyl infusion and 1hour after initiation of remifentanil analgesia during the first phase of delivery
    • To evaluate the efficacy of remifentanil analgesia during the first phase of delivery in parturients by observing changes in VAS score

Secondary Measures

  • Patient satisfaction with analgetic method
    • Time Frame: Before initiation of anagetic method (first phase of delivery) and 1hour after childbirth
    • Patients will fill the questionaire to obtain their opinion on the remifentanil analgesia

Participating in This Clinical Trial

Inclusion Criteria

  • parturients during the delivery – administered remifentanil analgesia – signed informed consent Exclusion Criteria:

  • informed consent not signed – missing data about the analgetic method a analgetic efficacy

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 50 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Brno University Hospital
  • Collaborator
    • Hospital Sokolov
  • Provider of Information About this Clinical Study
    • Principal Investigator: Petr Štourač, MD, MD, Ph.D – Brno University Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.